Kim Chul Ho, Jeon Jin Pyeong, Kim Sung-Eun, Choi Hyuk Jai, Cho Yong Jun
Department of Neurology, Hallym University College of Medicine, Chuncheon, Korea.
Department of Neurosurgery, Hallym University College of Medicine, Chuncheon, Korea.
J Korean Neurosurg Soc. 2018 Jul;61(4):467-473. doi: 10.3340/jkns.2017.0505.006. Epub 2018 Apr 10.
The aim of this study was to determine outcome of ischemic stroke patients in the anterior circulation treated with endovascular treatment (EVT) with intravenous thrombolysis (IVT) versus EVT alone group.
A systemic literature review was performed using online database from January 2004 to January 2017. Primary outcomes were successful recanalization seen on finial angiography and good outcome at three months. Secondary outcomes were mortality and the development of symptomatic intracranial hemorrhage (S-ICH) after the procedure. A fixed effect model was used when heterogeneity was less than 50%. Egger's regression test was used to assess publication bias.
Five studies were included for final analysis. Between EVT with IVT and EVT alone group, successful recanalization (odds ratio [OR] 1.467, p=0.216), good clinical outcome at three months (OR 1.199, p=0.385), mortality (OR 0.776, p=0.371), and S-ICH (OR 1.820, p=0.280) did not differ significantly. Egger's regression intercept with 95% confidence interval (CI) was 1.99 (95% CI -2.91 to 6.89) in successful recanalization and -0.27 (95% CI -6.35 to 5.80) in good clinical outcome, respectively.
The two treatment modalities, EVT with IVT and EVT alone, could be comparable in treating acute anterior circulation stroke. Studies to find specific beneficiary group for EVT alone, without primary IVT, are needed further.
本研究旨在确定接受血管内治疗(EVT)联合静脉溶栓(IVT)与单纯EVT治疗的前循环缺血性卒中患者的预后情况。
使用在线数据库对2004年1月至2017年1月期间的文献进行系统回顾。主要结局为最终血管造影显示的成功再通以及3个月时的良好预后。次要结局为术后死亡率和症状性颅内出血(S-ICH)的发生情况。当异质性小于50%时,使用固定效应模型。采用Egger回归检验评估发表偏倚。
五项研究纳入最终分析。在EVT联合IVT组与单纯EVT组之间,成功再通(优势比[OR]1.467,p = 0.216)、3个月时良好临床结局(OR 1.199,p = 0.385)、死亡率(OR 0.776,p = 0.371)和S-ICH(OR 1.820,p = 0.280)差异均无统计学意义。Egger回归截距及其95%置信区间(CI)在成功再通方面为1.99(95%CI -2.91至6.89),在良好临床结局方面为-0.27(95%CI -6.35至5.80)。
EVT联合IVT与单纯EVT这两种治疗方式在治疗急性前循环卒中方面可能具有可比性。需要进一步开展研究以寻找无需初始IVT的单纯EVT的特定受益人群。